Showing results (1041-1050 of 1,084) with videos related to

Sort By:
Pageof 109
Nature Genetics|October 19, 2023
Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseasesMargaret G Guo, David L Reynolds, Cheen E Ang, et al.
BMJ (Clinical Research Ed.)|March 27, 2024
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort studyShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
Nanotoxicology|May 22, 2019
The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond - a reportVivien Stuttgen, Hugh E Giffney, Ayana Anandan, et al.
Nature Medicine|May 9, 2024
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitisMolly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, et al.
MMWR. Morbidity and Mortality Weekly Report|April 9, 2026
Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023Naeemah Logan, Meseret G Birhane, Sharla L McDonald, et al.
Nature Genetics|February 17, 2025
Functional analysis of cancer-associated germline risk variantsLaura N Kellman, Poornima H Neela, Suhas Srinivasan, et al.
Ecology Letters|May 19, 2015
Biodiversity mediates top-down control in eelgrass ecosystems: a global comparative-experimental approachJ Emmett Duffy, Pamela L Reynolds, Christoffer Boström, et al.
Journal of the American Academy of Dermatology|February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapyNga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Nature Communications|September 25, 2025
Disease-linked regulatory DNA variants and homeostatic transcription factors in epidermisDouglas F Porter, Robin M Meyers, Weili Miao, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter StudyFrank B Cortazar, Zoe A Kibbelaar, Ilya G Glezerman, et al.
Pageof 109